CELL

COM:CELLCENTRIC

CellCentric

  • Privately Held

CellCentric is a clinical stage biotech company focused on the development of a p300/CBP inhibitor to treat specific cancer types, notably multiple myeloma. The drug, inobrodib, is currently evaluated for safety and effectiveness in multiple specific settings.

competitor of